¹ÚÀ±Á¤ ¸íÀÇ

·ù¸¶Æ¼½º°üÀý¿° Ä¡·á ȯ°æÀ» °³¼±Çϱâ À§ÇØ ¾ÕÀå

¹ÚÀ±Á¤ ¸íÀÇ

  • ¼Ò ¼Ó
    °¡Å縯´ë¼ººó¼¾Æ®º´¿ø ·ù¸¶Æ¼½º³»°ú
  • Àü¹®ºÐ¾ß
    ·ù¸¶Æ¼½º °üÀý¿°, ·çǪ½º, º£Ã¼Æ®, °­Á÷¼ºÃ´Ãß¿°, ¿°Áõ¼º±Ù¿°

·ù¸¶Æ¼½º°üÀý¿°ÀÇ Áø´Ü ¸¶Ä¿¸¦ ¹ß±¼ÇÏ°í °­Á÷¼º ôÃß¿°ÀÇ Á¤·®Àû °ñ ¼Õ»ó Æò°¡ ¹× ÁöÇ¥¸¦ °³¹ßÇÏ´Â µî ·ù¸¶Æ¼½º°üÀý¿° Ä¡·á ȯ°æÀ» °³¼±Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °¡Å縯´ëÇб³ ÀÇÇÐ Çлç
  • °¡Å縯´ëÇб³ ³»°úÇÐ ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °¡Å縯´ë ¼ººó¼¾Æ®º´¿ø ·ù¸¶Æ¼½º³»°ú ±³¼ö
  • ¿©Àǵµ¼º¸ðº´¿ø ·ù¸¶Æ¼½º³»°ú ÀÓ»ó°­»ç (2008 ~ 2010)
  • °¡Å縯´ë ¼ººó¼¾Æ®º´¿ø ·ù¸¶Æ¼½º³»°ú ÀÓ»óÁ¶±³¼ö (2010 ~ 2014)
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Serial changes in the coronary artery: Isolated immunoglobulin G4-related coronary arteritis
¹ßÇ¥³âµµ 2023.10 ¹ßÇ¥Áö EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING
Á¦ ¸ñ Quantitative prediction of radiographic progression in patients with axial spondyloarthritis using neural network model in a real-world setting
¹ßÇ¥³âµµ 2023.04 ¹ßÇ¥Áö ARTHRITIS RESEARCH & THERAPY
Á¦ ¸ñ Pyoderma Gangrenosum Triggered by COVID-19 Vaccination in a Patient with Ulcerative Colitis: A Case Report
¹ßÇ¥³âµµ 2022.11 ¹ßÇ¥Áö INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS
Á¦ ¸ñ Denosumab-Related Osteonecrosis of the Jaw May Not Be a Subject of Teriparatide Treatment
¹ßÇ¥³âµµ 2022.10 ¹ßÇ¥Áö JOURNAL OF BONE AND MINERAL RESEARCH
Á¦ ¸ñ Use of Disease-modifying Antirheumatic Drugs After Cancer Diagnosis in Rheumatoid Arthritis Patients
¹ßÇ¥³âµµ 2022.07 ¹ßÇ¥Áö JOURNAL OF RHEUMATIC DISEASES(´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö)
Á¦ ¸ñ Clinical Implications of Shared Epitope and Anti-citrullinated Peptide Antibody in Patients With Rheumatoid Arthritis
¹ßÇ¥³âµµ 2022.07 ¹ßÇ¥Áö JOURNAL OF RHEUMATIC DISEASES(´ëÇÑ·ù¸¶Æ¼½ºÇÐȸÁö)
Á¦ ¸ñ Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
¹ßÇ¥³âµµ 2022.07 ¹ßÇ¥Áö LANCET

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°¡Å縯´ë¼ººó¼¾Æ®º´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1577-8588
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿øÀº °æ±â³²ºÎÁö¿ª ÃÖÃÊÀÇ Àǰú´ëÇк´¿øÀ¸·Î 1967³â °³¿øÇß´Ù. ¼ººó¼¾Æ®º´¿øÀº ¡®ÀüÀÎ Ä¡·á ½ÇÇö¡¯À» ¸ñÇ¥·Î °í³­µµ ÁßÁõ Áúȯ Áß½ÉÀÇ Áø·á ¿ª·® °­È­¸¦ ÅëÇÑ ÀÇ·áÀÇ ÁúÀû ¼öÁØ Çâ»ó°ú ȯÀÚ Áß½ÉÀÇ ÄèÀûÇÏ°í Æí¾ÈÇÑ Áø·á ȯ°æ ¹× È¿À²ÀûÀÎ Áø·á ½Ã½ºÅÛ ±¸ÃàÀ» À§ÇØ ´Ù°¢µµÀÇ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖ´Ù. ¾Ïº´¿ø ¹× ½É³úÇ÷°üº´¿ø, ·Îº¿¼ö¼ú¼¾ÅÍ, ÇÏÀ̺긮µåÇ÷°ü¼¾ÅÍ µî ÃÖ÷´Ü ÀÇ·á½Ã¼³°ú Àåºñ, ½Ç·Â ÀÖ´Â ÀÇ·áÁøµéÀ» °®Ãß°í, °í³­µµ ÁßÁõÁúȯÀ» Áß½ÉÀ¸·Î Áø·á ¿ª·® ÁýÁßÇϰí ÀÖ´Ù.

°¡Å縯´ë¼ººó¼¾Æ®º´¿ø À̹ÌÁö

°æ±âµµ ¼ö¿ø½Ã ÆÈ´Þ±¸ Áߺδë·Î 93

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä